R.M. Davis Inc’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.4M | Sell |
46,917
-2,941
| -6% | -$814K | 0.16% | 78 |
|
|
2026
Q1 | $14.7M | Sell |
49,858
-5,253
| -10% | -$1.56M | 0.26% | 74 |
|
|
2025
Q4 | $15M | Sell |
55,111
-5,442
| -9% | -$1.48M | 0.26% | 73 |
|
|
2025
Q3 | $16.4M | Sell |
60,553
-7,846
| -11% | -$2.13M | 0.29% | 72 |
|
|
2025
Q2 | $18.9M | Sell |
68,399
-20,157
| -23% | -$5.48M | 0.35% | 70 |
|
|
2025
Q1 | $23.5M | Sell |
88,556
-1,806
| -2% | -$445K | 0.47% | 62 |
|
|
2024
Q4 | $21M | Sell |
90,362
-4,404
| -5% | -$1.01M | 0.41% | 67 |
|
|
2024
Q3 | $20.9M | Sell |
94,766
-5,128
| -5% | -$1.06M | 0.4% | 70 |
|
|
2024
Q2 | $19.6M | Sell |
99,894
-3,367
| -3% | -$696K | 0.4% | 71 |
|
|
2024
Q1 | $22.2M | Sell |
103,261
-3,161
| -3% | -$664K | 0.47% | 67 |
|
|
2023
Q4 | $22.4M | Sell |
106,422
-3,137
| -3% | -$669K | 0.52% | 62 |
|
|
2023
Q3 | $21.9M | Sell |
109,559
-3,709
| -3% | -$737K | 0.55% | 60 |
|
|
2023
Q2 | $21M | Sell |
113,268
-13,808
| -11% | -$2.55M | 0.5% | 64 |
|
|
2023
Q1 | $24.3M | Buy |
127,076
+3,261
| +3% | +$590K | 0.62% | 57 |
|
|
2022
Q4 | $20.8M | Buy |
123,815
+11,518
| +10% | +$2M | 0.56% | 62 |
|
|
2022
Q3 | $19.9M | Buy |
112,297
+5,577
| +5% | +$1.1M | 0.58% | 61 |
|
|
2022
Q2 | $21.8M | Buy |
106,720
+4,574
| +4% | +$970K | 0.61% | 62 |
|
|
2022
Q1 | $24.3M | Sell |
102,146
-2,037
| -2% | -$478K | 0.58% | 63 |
|
|
2021
Q4 | $23.8M | Sell |
104,183
-590
| -0.6% | -$130K | 0.53% | 65 |
|
|
2021
Q3 | $20.3M | Sell |
104,773
-449
| -0.4% | -$91K | 0.5% | 74 |
|
|
2021
Q2 | $22.4M | Sell |
105,222
-4,676
| -4% | -$987K | 0.56% | 68 |
|
|
2021
Q1 | $22.4M | Sell |
109,898
-10,251
| -9% | -$2.02M | 0.62% | 66 |
|
|
2020
Q4 | $21.9M | Sell |
120,149
-9,621
| -7% | -$1.64M | 0.63% | 62 |
|
|
2020
Q3 | $21.7M | Sell |
129,770
-4,706
| -3% | -$793K | 0.71% | 57 |
|
|
2020
Q2 | $21.9M | Buy |
134,476
+8,808
| +7% | +$1.58M | 0.78% | 52 |
|
|
2020
Q1 | $21.7M | Buy |
125,668
+888
| +0.7% | +$177K | 0.9% | 46 |
|
|
2019
Q4 | $25M | Buy |
124,780
+3,552
| +3% | +$729K | 0.82% | 51 |
|
|
2019
Q3 | $25.6M | Buy |
121,228
+6,278
| +5% | +$1.31M | 0.9% | 46 |
|
|
2019
Q2 | $22.3M | Buy |
114,950
+860
| +0.8% | +$159K | 0.79% | 55 |
|
|
2019
Q1 | $18.8M | Sell |
114,090
-6,008
| -5% | -$1.06M | 0.7% | 59 |
|
|
2018
Q4 | $22.6M | Buy |
120,098
+1,766
| +1% | +$326K | 0.92% | 46 |
|
|
2018
Q3 | $20.1M | Buy |
118,332
+6,745
| +6% | +$1.14M | 0.73% | 58 |
|
|
2018
Q2 | $18.3M | Buy |
111,587
+2,243
| +2% | +$366K | 0.71% | 57 |
|
|
2018
Q1 | $17.7M | Sell |
109,344
-1,615
| -1% | -$257K | 0.7% | 59 |
|
|
2017
Q4 | $16.2M | Buy |
110,959
+1,285
| +1% | +$183K | 0.64% | 63 |
|
|
2017
Q3 | $14.9M | Buy |
109,674
+184
| +0.2% | +$23.2K | 0.62% | 64 |
|
|
2017
Q2 | $13.7M | Buy |
109,490
+5,655
| +5% | +$676K | 0.58% | 66 |
|
|
2017
Q1 | $12.3M | Sell |
103,835
-9,130
| -8% | -$1.1M | 0.56% | 69 |
|
|
2016
Q4 | $13M | Sell |
112,965
-12,890
| -10% | -$1.43M | 0.62% | 63 |
|
|
2016
Q3 | $13.2M | Sell |
125,855
-3,975
| -3% | -$415K | 0.64% | 59 |
|
|
2016
Q2 | $12.6M | Buy |
129,830
+1,555
| +1% | +$147K | 0.62% | 61 |
|
|
2016
Q1 | $12.3M | Buy |
128,275
+13,510
| +12% | +$1.23M | 0.63% | 62 |
|
|
2015
Q4 | $10.4M | Buy |
114,765
+6,460
| +6% | +$608K | 0.53% | 65 |
|
|
2015
Q3 | $10M | Buy |
108,305
+16,760
| +18% | +$1.59M | 0.54% | 69 |
|
|
2015
Q2 | $8.52M | Buy |
91,545
+8,455
| +10% | +$789K | 0.44% | 72 |
|
|
2015
Q1 | $7.87M | Buy |
83,090
+20,530
| +33% | +$1.9M | 0.41% | 72 |
|
|
2014
Q4 | $5.55M | Buy |
62,560
+6,785
| +12% | +$575K | 0.31% | 76 |
|
|
2014
Q3 | $4.46M | Buy |
55,775
+7,710
| +16% | +$581K | 0.26% | 80 |
|
|
2014
Q2 | $3.41M | Buy |
48,065
+3,060
| +7% | +$215K | 0.2% | 85 |
|
|
2014
Q1 | $3.33M | Buy |
45,005
+11,545
| +35% | +$871K | 0.2% | 87 |
|
|
2013
Q4 | $2.63M | Buy |
+33,460
| New | +$2.62M | 0.16% | 89 |
|
Other funds holding CME
R.M. Davis Inc's CME Position: Q2 2026 in Review
R.M. Davis Inc reduced its CME Group (CME) stake by 5.9% in Q2 2026, selling an estimated $814K and leaving 46,917 shares worth $10.4M. The position accounts for 0.16% of the portfolio, ranked #78.
R.M. Davis Inc first reported a position in CME in Q4 2013 and has held it in 51 quarters since. The position peaked at $25.6M in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- R.M. Davis Inc held 46,917 shares of CME Group worth $10.4M as of Q2 2026.
- R.M. Davis Inc sold 2,941 CME Group shares in Q2 2026, an estimated $814K.
- CME Group made up 0.16% of R.M. Davis Inc's portfolio in Q2 2026, its #78 holding.
- R.M. Davis Inc first reported a position in CME Group in Q4 2013 and has held it in 51 quarters since.
- R.M. Davis Inc's CME Group position peaked at $25.6M in Q3 2019.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.